Combinatorial Delivery of Docetaxel- and Erlotinib-Loaded Functionalized Nanostructured Lipid Carriers for the Treatment of Triple-Negative Breast Cancer Using Quality-by-Design Approach
This study explored the combined administration of docetaxel (DOC) and erlotinib (ERL) using nanostructured lipid carriers (NLCs), with folic acid (FA) conjugation to enhance their synergistic anticancer efficacy against triple-negative breast cancer. NLCs were developed through hot melt homogenizat...
Saved in:
Main Authors: | Aiswarya Chaudhuri (Author), Dulla Naveen Kumar (Author), Saurabh Kumar Srivastava (Author), Dinesh Kumar (Author), Umesh Kumar Patil (Author), Avanish Singh Parmar (Author), Sanjay Singh (Author), Ashish Kumar Agrawal (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Emergence of Nanotechnology as a Powerful Cavalry against Triple-Negative Breast Cancer (TNBC)
by: Aiswarya Chaudhuri, et al.
Published: (2022) -
A Bacteriophage Microgel Effectively Treats the Multidrug-Resistant <i>Acinetobacter baumannii</i> Bacterial Infections in Burn Wounds
by: Deepa Dehari, et al.
Published: (2023) -
Development and Evaluation of Docetaxel-Loaded Nanostructured Lipid Carriers for Skin Cancer Therapy
by: Florentina-Iuliana Cocoș, et al.
Published: (2024) -
Therapeutic potential of venom peptides: insights in the nanoparticle-mediated venom formulations
by: Aditya Vivek Joglekar, et al.
Published: (2022) -
Nanostructured Lipid Carrier Co-Loaded with Docetaxel and Magnetic Nanoparticles: Physicochemical Characterization and In Vitro Evaluation
by: Auni Hamimi Idris, et al.
Published: (2023)